These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2705440)
1. B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features. Orfao A; Gonzalez M; San Miguel JF; Rios A; Canizo MC; Hernandez J; Maricato ML; Lopez Borrasca A Am J Hematol; 1989 May; 31(1):26-31. PubMed ID: 2705440 [TBL] [Abstract][Full Text] [Related]
2. Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia. Orfao A; Gonzalez M; San Miguel JF; Tomas JF; Canizo MC; Lopez-Berges MC; Moraleda JM; Lopez Borrasca A Haematologia (Budap); 1990; 23(1):49-56. PubMed ID: 2397923 [TBL] [Abstract][Full Text] [Related]
3. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders. Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia. Orfao A; Ciudad J; González M; San Miguel JF; García AR; López-Berges MC; Ramos F; Del Cañizo MC; Ríos A; Sanz M Leukemia; 1992 Jan; 6(1):47-51. PubMed ID: 1736013 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow histopathologic patterns and immunologic phenotype in B-cell chronic lymphocytic leukaemia. Orfao A; Gonzalez M; San Miguel J; Rios A; Caballero MD; Sanz M; Calmuntia MJ; Galindo P; Lopez Borrasca A Blut; 1988 Jul; 57(1):19-23. PubMed ID: 3260526 [TBL] [Abstract][Full Text] [Related]
6. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease. Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517 [TBL] [Abstract][Full Text] [Related]
7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia]. Szerafin L; Jakó J; Riskó F Orv Hetil; 2015 Apr; 156(15):592-7. PubMed ID: 25845318 [TBL] [Abstract][Full Text] [Related]
10. [CD5-negative B-cell chronic lymphocytic leukemia (B-CLL) associated with massive splenomegaly and without lymphadenopathy]. Yamada T; Ninomiya H; Horiuchi T; Takada K; Hato T; Yamauchi K; Yasukawa M; Fujita S Rinsho Ketsueki; 1995 Oct; 36(10):1230-2. PubMed ID: 8531336 [TBL] [Abstract][Full Text] [Related]
11. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197 [TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients. Vallespí T; Montserrat E; Sanz MA Br J Haematol; 1991 Apr; 77(4):478-85. PubMed ID: 2025572 [TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological findings in large B-cell chronic lymphocytic leukemia. Orfao A; Gonzalez M; San Miguel JF; Cañizo MC; Galindo P; Caballero MD; Jimenez R; Lopez Borrasca A Clin Immunol Immunopathol; 1988 Feb; 46(2):177-85. PubMed ID: 3257424 [TBL] [Abstract][Full Text] [Related]
14. Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia. Pinto A; Del Vecchio L; Carbone A; Roncadin M; Volpe R; Serraino D; Monfardini S; Colombatti A; Zagonel V Ann Oncol; 1991 Feb; 2 Suppl 2():107-13. PubMed ID: 2049307 [TBL] [Abstract][Full Text] [Related]
15. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. International CLL-IPI working group Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters? Molica S Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672 [TBL] [Abstract][Full Text] [Related]
17. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J; Babusíková O Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [TBL] [Abstract][Full Text] [Related]
18. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters. Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502 [TBL] [Abstract][Full Text] [Related]
19. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). Horny HP; Sotlar K; Stellmacher F; Valent P; Grabbe J J Clin Pathol; 2006 Mar; 59(3):264-8. PubMed ID: 16505276 [TBL] [Abstract][Full Text] [Related]
20. Natural history of stage A chronic lymphocytic leukaemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukaemia. Br J Haematol; 1990 Sep; 76(1):45-57. PubMed ID: 2223648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]